Allan Jonathan sold STOK
October 2, 2026 · Form 4 insider transaction
Allan Jonathan sold 627 shares of Stoke Therapeutics, Inc. at $26.33 per share, a transaction worth $16.5K. The trade was recorded as open-market sale under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 0 days after the transaction.
Direction
Disposed (sell-side)
Shares
627
Price
$26.33
Total value
$16.5K
InsiderAllan Jonathan
RoleOfficer
SecurityCommon Stock
Transaction codeS: Open-market sale
Transaction dateOctober 2, 2026
Filing dateOctober 2, 2026
Shares owned after20,598
OwnershipDirect
10b5-1 planYes
AmendedNo
Footnotes
This transaction was executed pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 10, 2025.